Crossmark

The prognostic and predictive values of differential expression of exosomal receptor tyrosine kinases and associated with the PI3K/AKT/mTOR signaling in breast cancer patients undergoing neoadjuvant chemotherapy

Crossref DOI link: https://doi.org/10.1007/s12094-022-02959-9

Published Online: 2022-10-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guney Eskiler, Gamze https://orcid.org/0000-0002-2088-9914
Kazan, Nur

Haciefendi, Ayten

Deveci Ozkan, Asuman

Ozdemir, Kayhan

Ozen, Mirac

Kocer, Havva Belma

Yilmaz, Fahri

Kaleli, Suleyman

Sahin, Elvan

Bilir, Cemil
Funding

Funding for this research was provided by:

Sakarya Üniversitesi (2019-6-23-178)
License Information

Text and Data Mining valid from 2022-10-01

Version of Record valid from 2022-10-01
More Information

Article History

Received: 4 July 2022

Accepted: 16 September 2022

First Online: 1 October 2022

Declarations

:

: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

: The study was conducted in accordance with the Declaration of Helsinki Principles, approval was obtained from the Ethics Committee of Sakarya University Faculty of Medicine (ethical review number: 71522473/050.01.04/330).

: Informed consent was obtained from all patients.

: All authors have given their consent for publication.

Document is current

Any future updates will be listed below